Prognostic effect of tuberculosis on patients with occupational lung diseases: A 13-year observational study in a nationwide cohort

由 Hung, Chung-Lin, Su, Po-Lan, Ou, Chih-Ying
發表在 Medicine (Baltimore) (2016)

Author response

由 Su, Po-Lan, Lin, Cheng-Yu, Lin, Sheng-Hsiang
發表在 J Clin Sleep Med (2020)

Alpha-1 Adrenergic-Antagonist Use Increases the Risk of Sleep Apnea: A Nationwide Population-Based Cohort Study

由 Su, Po-Lan, Lin, Wen-Kuei, Lin, Cheng-Yu, Lin, Sheng-Hsiang
發表在 J Clin Sleep Med (2019)

Limited predictability of maximal muscular pressure using the difference between peak airway pressure and positive end-expiratory pressure during proportional assist ventilation (P...

由 Su, Po-Lan, Kao, Pei-Shan, Lin, Wei-Chieh, Su, Pei-Fang, Chen, Chang-Wen
發表在 Crit Care (2016)

Positive end-expiratory pressure selection based on best respiratory system compliance or collapse/hyperdistension curves in patients with acute respiratory distress syndrome: lack...

由 Su, Po-Lan, Lin, Wei-Chieh, Ko, Yen-Fen, Su, Pei-Fang, Chen, Chang-Wen
發表在 Intensive Care Med (2017)

First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer

由 Su, Po‐Lan, Chen, Chian‐Wei, Wu, Yi‐Lin, Lin, Chien‐Chung, Su, Wu‐Chou
發表在 Thorac Cancer (2020)

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis

由 Chang, Wei-Yuan, Wu, Yi-Lin, Su, Po-Lan, Yang, Szu-Chun, Lin, Chien-Chung, Su, Wu-Chou
發表在 PLoS One (2018)

Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC

由 Lin, Chia-Ying, Chang, Chao-Chun, Su, Po-Lan, Lin, Chien-Chung, Tseng, Yau-Lin, Su, Wu-Chou, Yen, Yi-Ting
發表在 Medicine (Baltimore) (2019)

The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemic

由 Tsai, Chin-Shiang, Huang, Tang-Hsiu, Su, Po-Lan, Chen, Chiung-Zuei, Chen, Chang-Wen, Ko, Wen-Chien, Lee, Nan-Yao
發表在 J Formos Med Assoc (2022)

An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan

由 Wu, Shang-Gin, Chiang, Chi-Lu, Liu, Chien-Ying, Wang, Chin-Chou, Su, Po-Lan, Hsia, Te-Chun, Shih, Jin-Yuan, Chang, Gee-Chen
發表在 Front Oncol (2020)

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

由 Su, Po-Lan, Wu, Yi-Lin, Chang, Wei-Yuan, Ho, Chung-Liang, Tseng, Yau-Lin, Lai, Wu-Wei, Su, Wu-Chou, Lin, Chien-Chung, Yang, Szu-Chun
發表在 Ther Adv Med Oncol (2018)

Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC

由 Lin, Chien-Chung, Wu, Chin-You, Tseng, Joseph Ta-Chien, Hung, Chun-Hua, Wu, Shang-Yin, Huang, Yu-Ting, Chang, Wei-Yuan, Su, Po-Lan, Su, Wu-Chou
發表在 Biomedicines (2021)

Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment

由 Su, Po‐Lan, Yang, Szu‐Chun, Chen, Yi‐Lin, Wu, Yi‐Lin, Lin, Chia‐Ying, Chang, Wei‐Yuan, Tseng, Yau‐Lin, Lai, Wu‐Wei, Ho, Chung‐Liang, Lin, Chien‐Chung, Su, Wu‐Chou
發表在 Cancer Med (2019)

Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy

由 Chang, Hsien-Yuan, Lee, Chun-Hui, Su, Po-Lan, Li, Sin-Syue, Chen, Ming-Yueh, Chen, Ya-Ping, Hsu, Ya-Ting, Tsai, Wei-Chuan, Liu, Ping-Yen, Chen, Tsai-Yun, Liu, Yen-Wen
發表在 Sci Rep (2021)

The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicente...

由 Huang, Yen-Hsiang, Hung, Jen-Yu, Ko, How-Wen, Su, Po-Lan, Lai, Chun-Liang, Chang, Huang-Chih, Hsia, Te-Chun, Lin, Sheng-Hao, Wu, Kuan-Li, Yang, Cheng-Ta, Su, Wu-Chou, Chu, Yi-Chun, Wang, Chin-Chou, Liao, Wei-Yu, Lin, Yen-Ting, Lin, Ching-Hsiung, Lin, Meng-Chih, Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Yang, Tsung-Ying, Chen, Kun-Chieh, Lee, Mei-Hsuan, Yu, Sung-Liang, Ho, Chao-Chi, Chang, Gee-Chen
發表在 Ther Adv Med Oncol (2021)